DAVID CASTELLONE: Open Payments
NPI 1356308654 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,543 in 86 payments from 31 companies in 2025. Trend: 2023 $1,791 · 2024 $1,574 · 2025 $1,543
Food & beverage: $1,543
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $176 |
| Novo Nordisk Inc | 10 | $161 |
| ABBVIE INC. | 15 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $112 |
| PFIZER INC. | 6 | $103 |
| Amgen Inc. | 5 | $83 |
| Esperion Therapeutics, Inc. | 4 | $70 |
| Phathom Pharmaceuticals, Inc. | 3 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $55 |
| Lilly USA, LLC | 3 | $54 |
Products named: CAPLYTA, FARXIGA, Wegovy, NEXLETOL, PREVNAR 20, VRAYLAR, VOQUEZNA, GEMTESA.
Industry payments across SC — which companies pay providers there.
